Medical News Today: Immunotherapy found safe for type 1 diabetes in landmark trial

A new trial investigates the safety profile of proinsulin peptide immunotherapy for treating type 1 diabetes, and the results are encouraging.

This post was syndicated from Featured Health News from Medical News Today. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply